First results from recent JET experiments in Hydrogen and Hydrogen-Deuterium plasmas

The hydrogen campaign completed at JET in 2016 has demonstrated isotope ratio control in JET-ILW using gas puffing and pellets for fuelling, Neutral Beam Injection alone or in combination, with D/H spectroscopy as a diagnostic. The plasma properties such as confinement, L-H threshold, density limit depend on the isotope composition. The L-H transition power increases with the hydrogen concentration with a wide plateau in the range 0.2<nH/(nD+nH)<0.8. Energy confinement is significantly lower in hydrogen than in comparable deuterium ELMy H-mode plasmas, suggesting an isotope mass scaling that is stronger than in IPB98(y,2). In L-mode, the isotope dependence of confinement is weaker. The H-mode density limit in hydrogen is up to 35% lower than in heuterium, whilst it is found to be higher in L-mode. The lower ion mass leads to reduced tungsten sputtering in hydrogen plasmas. During the campaign, the nD/(nD+nH) ratio dropped to ~1% in only a few discharges after the last deliberate introduction of deuterium, although it was seen to rise again to ~2% with several seconds of exposure of the divertor tiles to ~10MW of auxiliary heating. Several ICRH scenarios were also tested in hydrogen plasmas

Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2

The COVID-19 pandemic is ongoing, and the need for safe and effective vaccines to prevent infection and to control spread of the virus remains urgent. Here, we report the development of a SARS-CoV-2 subunit vaccine candidate (Betuvax-CoV-2) based on RBD and SD1 domains of the spike (S) protein fused to a human IgG1 Fc fragment. The antigen is adsorbed on betulin adjuvant, forming spherical particles with a size of 100&ndash;180 nm, mimicking the size of viral particles. Here we confirm the potent immunostimulatory activity of betulin adjuvant, and demonstrate that two immunizations of mice with Betuvax-CoV-2 elicited high titers of RBD-specific antibodies. The candidate vaccine was also effective in stimulating a neutralizing antibody response and T cell immunity. The results indicate that Betuvax-CoV-2 has good potential for further development as an effective vaccine against SARS-CoV-2

FORMULATION OF MATHEMATICAL PROBLEM DESCRIBING PHYSICAL AND CHEMICAL PROCESSES AT CONCRETE CORROSION

The article deals with the relevance of new scientific research focused on modeling of physical and chemical processes occurring in the cement concrete at their exploitation. The basic types of concrete corrosion are described. The problem of mass transfer processes in a flat reinforced concrete wall at concrete corrosion of the first and the second types has been mathematically formulated

Reply to the comment by M. Mazdziarz on the article "Ab initio calculations of pressure-dependence of high-order elastic constants using finite deformations approach" [Computer Physics Communications 220 (2017) 20-30]

Marcin Mazdziarz has published a comment on our recent paper by I. Mosyagin, A.V. Lugovskoy, O.M. Krasilnikov, Yu.Kh. Vekilov, S.I. Simak and L.A. Abrikosov titled "Ab initio calculations of pressure dependence of high-order elastic constants using finite deformations approach" [Computer Physics Communications 220 (2017)2030]. The author states that there are serious fundamental errors and flaws. In this reply we clarify all misunderstanding mentioned in the said comment. (C) 2018 Published by Elsevier B.V.Funding Agencies|Swedish Research Council [2015-04391, 2014-4750]; Swedish Government Strategic Research Area in Materials Science on Functional Materials at Linkoping University [2009 00971]; Ministry of Education and Science of the Russian Federation [K2-2017-080, 14.Y26.31.0005]</p

Nonlinear elasticity of epsilon -Fe: The pressure effect

Description of elasticity of iron at the ultrahigh pressures is a challenging task for physics, with a potential strong impact on other branches of science. In the present work, we calculate the elastic properties of hcp iron in the pressure range of 50-340 GPa beyond the linear elasticity approximation, conventionally assumed in theoretical studies. We define the higher order elastic constants and present expressions for the long-wave acoustic modes Gruneisen parameters of a compressed hcp crystal. We obtain the second and third order elastic constants of the hcp Fe in the considered pressure interval, as well as its Gruneisen parameters for the high-symmetry directions. The latter are directly compared with the Gruneisen parameters derived from the volume dependences of the vibrational frequencies calculated in the quasiharmonic approximation. The obtained results are used for the stability analysis of the hcp phase of iron at high pressures.Funding Agencies|Russian Science Foundation [18-12-00492]; Swedish Research Council [2015-04391]</p

Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2

The COVID-19 pandemic is ongoing, and the need for safe and effective vaccines to prevent infection and to control spread of the virus remains urgent. Here, we report the development of a SARS-CoV-2 subunit vaccine candidate (Betuvax-CoV-2) based on RBD and SD1 domains of the spike (S) protein fused to a human IgG1 Fc fragment. The antigen is adsorbed on betulin adjuvant, forming spherical particles with a size of 100–180 nm, mimicking the size of viral particles. Here we confirm the potent immunostimulatory activity of betulin adjuvant, and demonstrate that two immunizations of mice with Betuvax-CoV-2 elicited high titers of RBD-specific antibodies. The candidate vaccine was also effective in stimulating a neutralizing antibody response and T cell immunity. The results indicate that Betuvax-CoV-2 has good potential for further development as an effective vaccine against SARS-CoV-2

Shaping Triangular Picosecond Laser Pulses for Electron Photoinjectors

Beam driven wakefield acceleration is one of the most advanced novel accelerator concepts.This process occurs in a plasma or a slow-wave structure in which the drive beam depositsenergy in the form of a wake and the main beam is accelerated by this wake. For efficientacceleration, it is important to shape the drive beam current and to increase the so-calledtransformer ratio: the energy gain by the main beam to the energy loss of the drive beam.Triangular bunch shapes are among the most promising distributions considered for increasingthe transformer ratio. In most cases, the drive beam is shaped with the help of electron beamphase space manipulation along with removal of portions of the beam with a scraper. This typeof shaping is complicated by itself, causing charge loss and thermal heating, but also leads tobeam instabilities due to the altered phase space of the beam. In this paper, we demonstrateexperimentally the shaping of picosecond laser pulses in the form of a triangle with the helpof a spatial light modulator. Such laser pulses can be used to generate a triangular electronbunch from a photoinjector. Considerations on the required pulse profile, comparison to othershaping methods, experimental results, and numerical analysis of the impact of pulse shaperparameters on the reproducibility of the triangular laser pulse shape are presented

SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study

Public health threat coming from a rapidly developing COVID-19 pandemic calls for developing safe and effective vaccines with innovative designs. This paper presents preclinical trial results of “Betuvax-CoV-2”, a vaccine developed as a subunit vaccine containing a recombinant RBD-Fc fusion protein and betulin-based spherical virus-like nanoparticles as an adjuvant (“Betuspheres”). The study aimed to demonstrate vaccine safety in mice, rats, and Chinchilla rabbits through acute, subchronic, and reproductive toxicity studies. Along with safety, the vaccine demonstrated protective efficacy through SARS-CoV-2-neutralizing antibody production in mice, rats, hamsters, rabbits, and primates (rhesus macaque), and lung damage and infection protection in hamsters and rhesus macaque model. Eventually, “Betuvax-CoV-2” was proved to confer superior efficacy and protection against the SARS-CoV-2 in preclinical studies. Based on the above results, the vaccine was enabled to enter clinical trials that are currently underway

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

COVID-19, being a life-threatening infection that evolves rapidly, remains a major public health concern calling for the development of vaccines with broad protection against different pathogenic strains and high immunogenicity. Aside from this, other concerns in mass immunization settings are also the scalability of production and relative affordability of the technology. In that regard, adjuvanted protein vaccines with particles mimicking the virus stand out among known vaccine technologies. The “Betuvax-CoV-2” vaccine, developed on the basis of a recombinant protein and an adjuvant, has already been tested in preclinical studies and has advanced to clinical evaluation. Open, double-blinded, placebo-controlled, randomized phase I/II clinical trial of the “Betuvax-CoV-2,” recombinant protein subunit vaccine based on the S-protein RBD fused with the Fc-fragment of IgG, was conducted to evaluate safety and immunogenicity in response to the vaccination. Methods: In the phase I/II clinical trial, 116 healthy adult men and women, ages 18–58, were enrolled: 20 in Stage I, and 96 in Stage II. In Stage I, 20 µg of the vaccine was administered intramuscularly on day 2, and either 5 µg (group 1) or 20 µg (group 2) on day 30. In Stage II, 20 µg of the vaccine was administered intramuscularly on day 2, and either 5 µg (group 3) or 20 µg (group 4) on day 30. In group 5, both injections were replaced with placebo. The primary outcome measures were safety (number of participants with adverse events throughout the study) and antigen-specific humoral immunity (SARS-CoV-2-specific antibodies measured by ELISA and CMIA). Antigen-specific cell-mediated immunity and changes in neutralizing antibodies (detected with a SARS-CoV-2 neutralization assay) were measured as a secondary outcome. The trial is registered with ClinicalTrials.gov (Study Identifier: NCT05270954). Findings: Both vaccine formulations (20 µg + 5 µg and 20 µg + 20 µg) were safe and well tolerated. Most adverse events were mild, and no serious adverse events were detected. On day 51,anti-SARS-CoV-2 total and IgG antibody titers and anti-SARS-CoV-2 neutralizing antibodies were significantly higher in the vaccine groups (both formulations) than in the placebo. A more pronounced CD4+-mediated immune response was observed in the group of volunteers administered with the 20 + 20 μg vaccine formulation. Interpretations: RBD-Fc-based COVID-19 “Betuvax-CoV-2” vaccine in doses (20 + 5 µg and 20 + 20 µg) demonstrated an excellent safety profile and induced a strong humoral response. Further research on the protective effectiveness of the “Betuvax-CoV-2” vaccine for the prevention of COVID-19 is on its way

Alkyl Derivatives of Perylene Photosensitizing Antivirals: Towards Understanding the Influence of Lipophilicity

Amphipathic perylene derivatives are broad-spectrum antivirals against enveloped viruses that act as fusion inhibitors in a light-dependent manner. The compounds target the lipid bilayer of the viral envelope using the lipophilic perylene moiety and photogenerating singlet oxygen, thereby causing damage to unsaturated lipids. Previous studies show that variation of the polar part of the molecule is important for antiviral activity. Here, we report modification of the lipophilic part of the molecule, perylene, by the introduction of 4-, 8-, and 12-carbon alkyls into position 9(10) of the perylene residue. Using Friedel–Crafts acylation and Wolff–Kishner reduction, three 3-acetyl-9(10)-alkylperylenes were synthesized from perylene and used to prepare 9 nucleoside and 12 non-nucleoside amphipathic derivatives. These compounds were characterized as fluorophores and singlet oxygen generators, as well as tested as antivirals against herpes virus-1 (HSV-1) and vesicular stomatitis virus (VSV), both known for causing superficial skin/mucosa lesions and thus serving as suitable candidates for photodynamic therapy. The results suggest that derivatives with a short alkyl chain (butyl) have strong antiviral activity, whereas the introduction of longer alkyl substituents (n = 8 and 12) to the perylenyethynyl scaffold results in a dramatic reduction of antiviral activity. This phenomenon is likely attributable to the increased lipophilicity of the compounds and their ability to form insoluble aggregates. Moreover, molecular dynamic studies revealed that alkylated perylene derivatives are predominately located closer to the middle of the bilayer compared to non-alkylated derivatives. The predicted probability of superficial positioning correlated with antiviral activity, suggesting that singlet oxygen generation is achieved in the subsurface layer of the membrane, where the perylene group is more accessible to dissolved oxygen